I disagree. Instead, I believe Singapore market is one of the most important market as far as SE Asia market is concerned. Reason is really simple. Neighboring countries like Malaysia, Indonesia, Thailand, e.t.c looks up to the Singaporean healthcare standard. If Painchek is successfully implemented in Singapore, it will be easier to implement in those other countries. They will trust Painchek because Singapore has approved and used it. So, really, PD's move into Singapore is most strategic
pck chart, page-2670
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
